Your Best Stock
Stocks › CAR-T Therapy › AMGN

Amgen AMGN

US equityMarket cap rank #67CAR-T Therapy
$405.48
−$0.61 (-0.15%)
Market open · Sep 24, 2:00 pm ET
After hours $405.00 -0.27%
Open$406.09
Prev close$406.09
Day range$403.88 – $409.99
Volume706.4K
Market cap$219.22B
P/E (TTM)25.2
Dividend yield2.42%

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$10.05B+9.5% YoY
Operating profit$3.51B+32.3% YoY
Net profit$2.38B+65.9% YoY
Diluted EPS$4.37+64.9% YoY
Free cash flow$3.49B+82.6% YoY
Operating cash flow$4.00B

Revenue, last 8 quarters

$8.5BSep '24$9.1BDec '24$8.1BMar '25$9.2BJun '25$9.6BSep '25$9.9BDec '25$8.6BMar '26$10.1BJun '26

Net profit, last 8 quarters

$2.8BSep '24$627.0MDec '24$1.7BMar '25$1.4BJun '25$3.2BSep '25$1.3BDec '25$1.8BMar '26$2.4BJun '26

Diluted EPS by quarter

5.22Sep '241.16Dec '243.20Mar '252.65Jun '255.93Sep '252.45Dec '253.34Mar '264.37Jun '26

Free cash flow by quarter

$3.3BSep '24$4.4BDec '24$980.0MMar '25$1.9BJun '25$4.2BSep '25$961.0MDec '25$1.5BMar '26$3.5BJun '26

Annual revenue

$25.4BFY20$26.0BFY21$26.3BFY22$28.2BFY23$33.4BFY24$36.8BFY25

Profitability & balance sheet

Gross margin69.5%
Operating margin30.0%
Net margin23.0%
Return on equity91.5%
Return on assets9.5%
Return on invested capital16.6%
Current ratio1.37
Liabilities / assets87.8%
Cash & investments$13.99B
Total debt$57.30B
Net cash (debt)-$43.32B
Free cash flow / sales26.7%

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Other$3.28B 32.6%
  • Other products$1.70B 16.9%
  • Repatha$953.00M 9.5%
  • Prolia$759.00M 7.5%
  • EVENITY$714.00M 7.1%
  • Enbrel$580.00M 5.8%
  • TEPEZZA$576.00M 5.7%
  • Other revenues$517.00M 5.1%
  • Otezla$491.00M 4.9%
  • TEZSPIRE$486.00M 4.8%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $10.05B $8.62B $36.75B $9.87B $9.56B
Total Operating Revenue $10.05B $8.62B $36.75B $9.87B $9.56B
Cost of Revenue $2.81B $2.74B $12.04B $2.98B $3.08B
Gross Profit $7.24B $5.87B $24.71B $6.89B $6.48B
Operating Expense $3.73B $3.21B $15.63B $4.17B $3.95B
Selling and Admin Expenses $1.75B $1.60B $7.05B $1.95B $1.72B
Research & Development $1.87B $1.72B $7.27B $2.14B $1.90B
Other Operating Expenses $116.00M -$113.00M $1.31B $76.00M $329.00M
Operating Profit $3.51B $2.67B $9.08B $2.72B $2.53B
Net Non-Operating Interest Income (Expense) -$673.00M -$657.00M -$2.76B -$653.00M -$685.00M
Non-Operating Interest Expense $673.00M $657.00M $2.76B $653.00M $685.00M
Other Income (Expense) -$73.00M $75.00M $2.65B -$553.00M $2.08B
Other Non-Operating Income (Expenses) -$73.00M $75.00M $2.65B -$553.00M $2.08B
Pretax Profit $2.77B $2.08B $8.98B $1.51B $3.92B
Tax $393.00M $265.00M $1.27B $181.00M $705.00M
Net Profit $2.38B $1.82B $7.71B $1.33B $3.22B
Profit from Continuing Operations $2.38B $1.82B $7.71B $1.33B $3.22B
Net Income to Parent Company $2.38B $1.82B $7.71B $1.33B $3.22B
Net Income to Common Stockholders $2.38B $1.82B $7.71B $1.33B $3.22B
Basic EPS $4.40 $3.37 $14.33 $2.47 $5.98
Diluted EPS $4.37 $3.34 $14.23 $2.45 $5.93
Dividend Per Share $2.52 $2.52 $9.52 $2.38 $2.38

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $95.64B $92.50B $90.59B $90.59B $90.14B
Total Current Assets $34.96B $31.48B $29.06B $29.06B $27.89B
Cash and Cash Equivalents & Short-Term Investments $13.99B $12.04B $9.13B $9.13B $9.45B
-Cash and Cash Equivalents $13.99B $12.04B $9.13B $9.13B $9.45B
Receivables $10.23B $9.14B $9.57B $9.57B $8.49B
-Accounts Receivable $10.23B $9.14B $9.57B $9.57B $8.49B
Inventory $6.22B $6.19B $6.23B $6.23B $6.35B
Other Current Assets $4.53B $4.11B $1.19B $1.19B $3.60B
Total Non-Current Assets $60.68B $61.03B $61.53B $61.53B $62.26B
Net PPE $8.55B $8.22B $7.91B $7.91B $7.22B
-Gross PPE $17.95B $17.52B $19.03B $19.03B $18.22B
-Accumulated Depreciation -$9.40B -$9.30B -$11.12B -$11.12B -$11.00B
Goodwill and Other Intangible Assets $39.16B $40.05B $40.96B $40.96B $41.82B
-Goodwill $18.67B $18.67B $18.68B $18.68B $18.68B
-Other Intangible Assets $20.49B $21.38B $22.28B $22.28B $23.14B
Other Non-Current Assets $12.98B $12.76B $12.66B $12.66B $13.22B
Total Liabilities $83.95B $83.31B $81.93B $81.93B $80.52B
Total Current Liabilities $25.50B $24.96B $25.49B $25.49B $21.79B
Payables $2.87B $2.94B $4.10B $4.10B $2.84B
-Accounts Payable $2.87B $2.94B $2.37B $2.37B $2.84B
Current Accrued Expenses $17.19B $16.58B $15.35B $15.35B $16.80B
Short-Term Debt and Capital Lease Obligation $5.45B $5.44B $4.60B $4.60B $2.15B
-Current Debt $5.45B $5.44B $4.60B $4.60B $2.15B
Total Non-Current Liabilities $58.45B $58.36B $56.44B $56.44B $58.73B
Long Term Accounts Payable and Other Payables $2.84B $2.76B $2.69B $2.69B $2.62B
Long Term Debt and Capital Lease Obligation $51.86B $51.89B $50.01B $50.01B $52.43B
-Long Term Debt $51.86B $51.89B $50.01B $50.01B $52.43B
Non-Current Deferred Liabilities $1.30B $1.34B $1.37B $1.37B $1.46B
Other Non-Current Liabilities $2.45B $2.37B $2.38B $2.38B $2.22B
Total Equity $11.69B $9.19B $8.66B $8.66B $9.62B
Stockholders' Equity $11.69B $9.19B $8.66B $8.66B $9.62B
Capital Stock $34.08B $34.03B $34.02B $34.02B $33.84B
-Common Stock $34.08B $34.03B $34.02B $34.02B $33.84B
Retained Earnings -$22.28B -$24.65B -$25.11B -$25.11B -$23.80B
Gains/Losses Not Affecting Retained Earnings -$119.00M -$190.00M -$258.00M -$258.00M -$422.00M
Prepaid Assets – – $2.95B $2.95B –
-Total Tax Payable – – $379.00M $379.00M –
-Dividends Payable – – $1.36B $1.36B –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $4.00B $2.19B $9.96B $1.60B $4.68B
Net cash flow from continuing operations $4.00B $2.19B $9.96B $1.60B $4.68B
Net Income from Continuing Operations $2.38B $1.82B $7.71B $1.33B $3.22B
Gain/Loss from Continuing Operations $158.00M $143.00M -$2.06B $648.00M -$1.97B
Depreciation & Depletion & Amortization $1.11B $1.12B $5.17B $1.13B $1.31B
Deferred Tax -$291.00M -$176.00M -$721.00M -$19.00M -$30.00M
Other Non-Cash Items $75.00M -$67.00M $149.00M $250.00M -$28.00M
Change in Working Capital $408.00M -$721.00M -$1.98B -$1.87B $1.66B
-Change in Receivables -$1.09B $413.00M -$2.68B -$1.08B $222.00M
-Change in Inventory -$31.00M $18.00M $886.00M $119.00M $240.00M
-Change in Payables and Accrued Expense -$124.00M $713.00M $736.00M $1.29B $510.00M
-Change in Other Current Assets -$330.00M $8.00M -$1.27B -$577.00M -$283.00M
-Change in Other Current Liabilities -$32.00M -$75.00M -$156.00M -$76.00M -$10.00M
-Change In Other Working Capital $2.02B -$1.80B $499.00M -$1.55B $984.00M
Net cash flow from investing -$569.00M -$716.00M -$1.94B -$693.00M -$414.00M
Net Cash Flow from Continuing Investing Activities -$569.00M -$716.00M -$1.94B -$693.00M -$414.00M
Net PPE Purchase and Sale -$513.00M -$712.00M -$1.86B -$642.00M -$436.00M
Net Other Investing Changes -$56.00M -$4.00M -$32.00M $2.00M $22.00M
Financing Cash Flow -$1.48B $1.44B -$10.86B -$1.23B -$2.85B
Net Cash Flow from Continuing Financing Activities -$1.48B $1.44B -$10.86B -$1.23B -$2.85B
Net Issuance Payments Of Debt $0.00 $3.13B -$5.00B $0.00 -$1.50B
Cash Dividends Paid -$1.36B -$1.36B -$5.12B -$1.28B -$1.28B
Net Other Financing Charges -$120.00M -$337.00M -$735.00M $57.00M -$71.00M
Ending Cash Balance $13.99B $12.04B $9.13B $9.13B $9.45B
Net Change in Cash $1.95B $2.91B -$2.84B -$316.00M $1.42B
Beginning Cash Balance $12.04B $9.13B $11.97B $9.45B $8.03B
Free Cash Flow $3.49B $1.48B $8.10B $961.00M $4.25B
Net Business Purchase and Sale – – -$53.00M – –
Net Investment Purchase and Sale – – $0.00 – –
Net Common Stock Issuance – – $0.00 – –
Scroll to Top